[1]叶芳芳,周志明,曾文宏.哌拉西林钠他唑巴坦钠联合左氧氟沙星对支气管扩张患者气道功能、炎症反应的影响[J].医学信息,2023,36(01):103-106.[doi:10.3969/j.issn.1006-1959.2023.01.020]
　YE Fang-fang,ZHOU Zhi-ming,ZENG Wen-hong.Effect of Piperacillin Sodium and Tazobactam Sodium Combined with Levofloxacin on Airway Function and Inflammatory Response in Patients with Bronchiectasis[J].Journal of Medical Information,2023,36(01):103-106.[doi:10.3969/j.issn.1006-1959.2023.01.020]
点击复制

哌拉西林钠他唑巴坦钠联合左氧氟沙星对支气管扩张患者气道功能、炎症反应的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年01期
页码:
103-106
栏目:
论著
出版日期:
2023-01-01

文章信息/Info

Title:
Effect of Piperacillin Sodium and Tazobactam Sodium Combined with Levofloxacin on Airway Function and Inflammatory Response in Patients with Bronchiectasis
文章编号:
1006-1959（2023）01-0103-04
作者:
叶芳芳; 周志明; 曾文宏
（吉水县人民医院呼吸内科，江西 吉水 331600）
Author(s):
YE Fang-fang; ZHOU Zhi-ming; ZENG Wen-hong
(Department of Respiratory Medicine,Jishui County People’s Hospital,Jishui 331600,Jiangxi,China)
关键词:
支气管扩张; 哌拉西林钠他唑巴坦钠; 左氧氟沙星; 气道功能; 炎症反应
Keywords:
Bronchiectasis; Piperacillin sodium and tazobactam sodium; Levofloxacin; Airway function; Inflammatory response
分类号:
R562.2+2
DOI:
10.3969/j.issn.1006-1959.2023.01.020
文献标志码:
A
摘要:
目的 分析哌拉西林钠他唑巴坦钠（PS/TS）联合左氧氟沙星对支气管扩张患者气道功能、炎症反应的影响。方法 选取吉水县人民医院于2019年3月-2021年6月收治的66例支气管扩张病例，按照随机数字表法分为对照组（33例）与观察组（33例）。对照组应用PS/TS治疗，观察组给予PS/TS联合左氧氟沙星治疗，比较两组气道功能[呼气峰值流速（PEF）、1 s用力呼气容积（FEV1）、用力肺活量比值（FEV1/FVC）]、血气分析指标[血氧饱和度（SaO2）、动脉血氧分压（PaO2）、动脉血二氧化碳分压（PaCO2）]、血清炎性因子[白细胞（WBC）、白介素6（IL-6）、C反应蛋白（CRP）]、症状改善情况[24 h痰液量、改良版英国医学研究委员会呼吸问卷（mMRC）评分、莱塞斯特咳嗽生命质量问卷（LCQ）评分]。结果 两组PEF、FEV1、FEV1／FVC均有升高，且观察组高于对照组（P＜0.05）；两组PaO2、SaO2升高，PaCO2下降，且观察组PaO2、SaO2高于对照组，PaCO2低于对照组（P＜0.05）；两组WBC、IL-6、CRP水平均有下降，且观察组较对照组低（P＜0.05）；两组24 h痰液量及mMRC、LCQ评分均有下降，且观察组低于对照组（P＜0.05）。结论 PS/TS与左氧氟沙星联合治疗支气管扩张，可有效改善患者气道功能，提升血氧状态，下调炎症表达，促进症状改善。
Abstract:
Objective To analyze the effects of piperacillin sodium and tazobactam sodium (PS/TS) combined with levofloxacin on airway function and inflammatory response in patients with bronchiectasis.Methods A total of 66 cases of bronchiectasis admitted to Jishui County People’s Hospital from March 2019 to June 2021 were selected and divided into control group (33 cases) and observation group (33 cases) according to the random number table method. The control group was treated with PS / TS, and the observation group was treated with PS/TS combined with levofloxacin. The airway function [peak expiratory flow (PEF), forced expiratory volume in one second (FEV1), forced expiratory volume in one second/ forced vital capacity (FEV1/FVC)], blood gas analysis indexes [saturation of blood oxygen (SaO2), arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2)], serum inflammatory factors [white blood cell (WBC), interleukin 6 (IL-6), C-reactive protein (CRP)], symptom improvement [24 h sputum volume, modified British Medical Research Council Respiratory Questionnaire (mMRC) score, Leicester Cough Quality of Life Questionnaire (LCQ) score] were compared between the two groups.Results PEF, FEV1 and FEV1/FVC in the two groups increased, and those in the observation group were higher than those in the control group (P<0.05). PaO2 and SaO2 in the two groups increased, PaCO2 decreased, and PaO2 and SaO2 in the observation group were higher than those in the control group, PaCO2 was lower than that in the control group (P<0.05). The levels of WBC, IL-6 and CRP in the two groups decreased, and those in the observation group were lower than those in the control group (P<0.05). The 24 h sputum volume, mMRC and LCQ scores of the two groups decreased, and those of the observation group were lower than those in the control group (P<0.05).Conclusion PS/TS combined with levofloxacin in the treatment of bronchiectasis can effectively improve airway function, improve blood oxygen status, down-regulate inflammatory expression and promote symptom improvement.

参考文献/References:

[1]刘楠,梁宗安,王君兰,等.阿奇霉素治疗支气管扩张症的临床疗效观察[J].实用心脑肺血管病杂志,2017,25(7):112-114.[2]Mcdonnell MJ,Aliberti S,Goeminne PC,et al.Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study[J].Lancet Respir Med,2016,4(12):969-979.[3]陈志洪,焉春华.哌拉西林舒巴坦与左氧氟沙星联合在慢性支气管炎患者的应用观察[J].山西医药杂志,2021,50(17):2538-2541.[4]钟巧,符英,蔡晓玉,等.哌拉西林钠舒巴坦钠联合左氧氟沙星治疗老年社区获得性肺炎及对可溶性髓样细胞触发受体1和高迁移率族蛋白B1水平的影响[J].老年医学与保健,2020,26(4):594-596,617.[5]张炜刚.左氧氟沙星氯化钠注射液联合阿奇霉素治疗慢性支气管炎的效果观察[J].中国药物与临床,2020,20(7):1152-1154.[6]支气管扩张症专家共识撰写协作组,中华医学会呼吸病学分会感染学组,瞿介明,等.中国成人支气管扩张症诊断与治疗专家共识[J].中华结核和呼吸杂志,2021,44(4):311-321.[7]陈刚,徐永芳,徐长青,等.哌拉西林/他唑巴坦联合依替米星治疗支气管扩张患者感染疗效的分析[J].中华医院感染学杂志,2016,26(9):1970-1972.[8]黄涛,陈春姣,胡晓华.美洛西林钠舒巴坦联合阿米卡星治疗支气管扩张并感染的有效性及安全性观察[J].解放军预防医学杂志,2019,37(3):124-125.[9]吴昕.三种大环内酯类药物治疗支气管扩张症的疗效分析[J].临床肺科杂志,2017,22(5):904-907.[10]Faverio P,Stainer A,Bonaiti G,et al.Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis[J].Int J Mol Sci,2016,17(11):1913.[11]武免免,刘雪健,廖明喻,等.支气管扩张急性加重期病原学分布及耐药性特征分析[J].中国医师进修杂志,2019(2):164-168.[12]张述琼,彭世秀.哌拉西林他唑巴坦联合环丙沙星治疗支气管扩张伴铜绿假单胞菌感染的临床研究[J].现代药物与临床,2018,33(8):1964-1968.[13]王建,王紫汀,朱莉,等.支气管扩张感染患者行哌拉西林钠他唑巴坦联合依替米星治疗的临床效果与安全性分析[J].中国病案,2018,19(8):96-98.[14]郭龙,朱国清,张亚飞.哌拉西林他唑巴坦对支气管扩张患者肺功能、血沉、C反应蛋白水平的影响及疗效分析[J].药物评价研究,2018,41(7):1272-1275.[15]於建平.哌拉西林钠他唑巴坦钠结合左氧氟沙星治疗慢性支气管炎对临床症状缓解时间的影响[J].重庆医学,2020,49(2):239-241.[16]王刚,焦成建.左氧氟沙星联合氨溴索对慢性支气管炎患者的疗效及免疫功能水平的影响[J].实用临床医药杂志,2019,23(7):76-79.[17]白植宽.左氧氟沙星联合哌拉西林钠/他唑巴坦钠对支气管扩张症铜绿假单胞菌急性感染者的疗效评估[J].中国微生态学杂志,2018,30(5):560-563.[18]陈勇,叶永青,刘国栋,等.支气管镜肺泡灌洗联合哌拉西林钠/舒巴坦钠对支气管扩张合并感染患者的治疗效果研究[J].四川医学,2017,38(3):302-305.[19]孙成春,李永芬,张欣悦,等.左氧氟沙星联合哌拉西林他唑巴坦对产超广谱β-内酰胺酶耐碳青霉烯类肺炎克雷伯菌的防耐药突变浓度及耐药机制的研究[J].中国医院药学杂志,2020,40(8):913-917.[20]徐琳,路苹,姚红梅,等.支气管扩张症合并感染患者血清人分泌型磷脂酶A2-X表达情况及其与炎性指标的相关性研究[J].中国全科医学,2020,23(24):3034-3039.[21]Chalmers JD,Ringshausen FC,Harris B,et al.Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network[J].Eur Respir J,2018,51(1):1701937.

相似文献/References:

[1]孟琳非,黄伟健,酆孟洁,等.基于聚类分析对慢性肺部疾病表型的研究进展[J].医学信息,2019,32(07):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
　MENG Lin-fei,HUANG Wei-jian,FENG Meng-jie,et al.Advances in Research on Phenotypes of Chronic Lung Diseases Based on Cluster Analysis[J].Journal of Medical Information,2019,32(01):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
[2]陈孝辉.哌拉西林钠他唑巴坦钠联合氨溴索治疗慢性阻塞性肺疾病的临床效果[J].医学信息,2022,35(13):97.[doi:10.3969/j.issn.1006-1959.2022.13.021]
　CHEN Xiao-hui.Clinical Effect of Piperacillin Sodium and Tazobactam Sodium Combined with Ambroxol in the Treatment of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(01):97.[doi:10.3969/j.issn.1006-1959.2022.13.021]
[3]曾文宏,叶芳芳,周志明.哌拉西林钠他唑巴坦钠联合左氧氟沙星治疗慢性支气管炎的临床疗效及安全性观察[J].医学信息,2022,35(23):140.[doi:10.3969/j.issn.1006-1959.2022.23.029]
　ZENG Wen-hong,YE Fang-fang,ZHOU Zhi-ming.Observation on Clinical Efficacy and Safety of Piperacillin Sodium and Tazobactam Sodium Combined with Levofloxacin in the Treatment of Chronic Bronchitis[J].Journal of Medical Information,2022,35(01):140.[doi:10.3969/j.issn.1006-1959.2022.23.029]
[4]罗之彦,刘小虹,江 勇.基于网络药理学研究黄芩-桑白皮药对治疗支气管扩张咯血的作用机制[J].医学信息,2023,36(16):21.[doi:10.3969/j.issn.1006-1959.2023.16.004]
　LUO Zhi-yan,LIU Xiao-hong,JIANG Yong.Mechanism of Scutellaria Baicalensis-Cortex Mori in the Treatment of Bronchiectasis with Hemoptysis Based on Network Pharmacology[J].Journal of Medical Information,2023,36(01):21.[doi:10.3969/j.issn.1006-1959.2023.16.004]
[5]彭水华,杨智文,廖乙媚,等.哌拉西林钠他唑巴坦钠相关腹泻的临床特征分析[J].医学信息,2024,37(04):61.[doi:10.3969/j.issn.1006-1959.2024.04.010]
　PENG Shui-hua,YANG Zhi-wen,LIAO Yi-mei,et al.Analysis of Clinical Characteristics of Diarrhea Caused by Piperacillin/Tazobactam[J].Journal of Medical Information,2024,37(01):61.[doi:10.3969/j.issn.1006-1959.2024.04.010]
[6]那君艳,谢晓靖.哌拉西林钠他唑巴坦钠治疗急性加重期慢性阻塞性肺疾病的临床疗效及不良反应[J].医学信息,2024,37(15):71.[doi:10.3969/j.issn.1006-1959.2024.15.015]
　NA Jun-yan,XIE Xiao-jing.Clinical Efficacy and Adverse Reactions of Piperacillin Sodium and Tazobactam Sodium in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2024,37(01):71.[doi:10.3969/j.issn.1006-1959.2024.15.015]
[7]孙蓉蓉,陈海涛,张尊敬.近十年中医药治疗支气管扩张症的可视化图谱分析[J].医学信息,2025,38(08):9.[doi:10.3969/j.issn.1006-1959.2025.08.002]
　SUN Rongrong,CHEN Haitao,ZHANG Zunjing.Visualization Map Analysis of Traditional Chinese Medicine in the Treatment of Bronchiectasis in Recent Ten Years[J].Journal of Medical Information,2025,38(01):9.[doi:10.3969/j.issn.1006-1959.2025.08.002]

更新日期/Last Update: 1900-01-01